Aldeyra Therapeutics
ALDX
ALDX
134 hedge funds and large institutions have $202M invested in Aldeyra Therapeutics in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 53 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.8% less ownership
Funds ownership: 65.51% → 64.71% (-0.8%)
2% less capital invested
Capital invested by funds: $205M → $202M (-$3.16M)
28% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 53
Holders
134
Holding in Top 10
1
Calls
$5.12M
Puts
$1.77M
Top Buyers
| 1 | +$3.65M | |
| 2 | +$2.66M | |
| 3 | +$1.3M | |
| 4 |
1CM
1492 Capital Management
Milwaukee,
Wisconsin
|
+$1.15M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.14M |
Top Sellers
| 1 | -$5.33M | |
| 2 | -$2.31M | |
| 3 | -$2.19M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.43M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$836K |
